INDV

INDIVIOR PLC ORD USD0.10

TitleTime
Holding(s) in CompanyFri 22/05/20 | 08:00
Indivior to Participate in ConferenceWed 20/05/20 | 14:00
1st Quarter ResultsThu 14/05/20 | 12:00
Holding(s) in CompanyThu 14/05/20 | 09:13
Block listing Interim ReviewMon 11/05/20 | 10:44
Result of AGMThu 07/05/20 | 17:23
Total Voting RightsFri 01/05/20 | 08:00
Directorate ChangeMon 27/04/20 | 07:00
Holding(s) in CompanyThu 23/04/20 | 16:37
Notice of ResultsMon 20/04/20 | 07:00
Important update regarding AGMThu 16/04/20 | 13:00
Indivior announces 12-month safety data publishedThu 16/04/20 | 07:00
Indivior Provides Business UpdateWed 08/04/20 | 07:00
Holding(s) in CompanyWed 25/03/20 | 15:47
Holding(s) in CompanyWed 25/03/20 | 15:20
Holding(s) in CompanyMon 23/03/20 | 15:47
One-Year Outcomes of RECOVER Study PublishedMon 23/03/20 | 09:00
Holding(s) in CompanyFri 20/03/20 | 13:09
Holding(s) in CompanyThu 19/03/20 | 14:35
Director/PDMR ShareholdingFri 13/03/20 | 14:00
Annual Financial ReportFri 13/03/20 | 12:00
Holding(s) in CompanyWed 11/03/20 | 15:57
Director/PDMR ShareholdingTue 10/03/20 | 14:30
Holding(s) in CompanyMon 09/03/20 | 09:11
Director/PDMR ShareholdingTue 03/03/20 | 14:31
Total Voting RightsMon 02/03/20 | 09:31
Director/PDMR ShareholdingTue 25/02/20 | 14:04
Director/PDMR ShareholdingTue 25/02/20 | 09:26
Holding(s) in CompanyFri 14/02/20 | 07:00
Board Committee ChangesThu 13/02/20 | 15:10
Final ResultsThu 13/02/20 | 07:00
Total Voting RightsMon 03/02/20 | 10:53
Holding(s) in CompanyWed 29/01/20 | 16:19
Notification of FY 2019 ResultsMon 13/01/20 | 07:00
Total Voting RightsThu 02/01/20 | 10:00
Holding(s) in CompanyThu 02/01/20 | 09:00
Holding(s) in CompanyWed 11/12/19 | 14:00
Holding(s) in CompanyWed 11/12/19 | 08:00
Indivior Announces New CollaborationTue 10/12/19 | 14:00
Additional ListingTue 10/12/19 | 09:00
Board Committee ChangeMon 09/12/19 | 14:30
Total Voting RightsMon 02/12/19 | 09:13
New SUBLOCADE outcomes analysis published in JSATMon 02/12/19 | 07:00
Indivior Launches National DTC Campaign in USTue 12/11/19 | 07:00
Block listing Interim ReviewMon 11/11/19 | 08:46
Holding(s) in CompanyWed 06/11/19 | 16:08
Indivior To Participate In Upcoming ConferencesMon 04/11/19 | 15:42
Board Committee ChangesThu 31/10/19 | 14:30
3rd Quarter ResultsThu 31/10/19 | 11:00
Directorate ChangeWed 16/10/19 | 09:30
Indivior Raises FY 2019 GuidanceTue 15/10/19 | 07:00
Holding(s) in CompanyThu 03/10/19 | 07:00
Notice of ResultsTue 01/10/19 | 07:00
Total Voting RightsTue 01/10/19 | 07:00
Indivior Receives US NIH Grant AwardFri 27/09/19 | 08:00
Holding(s) in CompanyFri 27/09/19 | 07:00
Total Voting RightsMon 02/09/19 | 10:58
Director/PDMR ShareholdingTue 13/08/19 | 14:30
Director/PDMR ShareholdingFri 09/08/19 | 07:00
Director/PDMR ShareholdingThu 08/08/19 | 14:30
Director/PDMR ShareholdingTue 06/08/19 | 14:00
Holding(s) in CompanyThu 01/08/19 | 15:37
Total Voting RightsThu 01/08/19 | 09:46
Directorate ChangesWed 31/07/19 | 07:01
Half-year ReportWed 31/07/19 | 07:00
Holding(s) in CompanyTue 30/07/19 | 10:21
Director's Change of ResponsibilitiesMon 29/07/19 | 14:00
Holding(s) in CompanyThu 25/07/19 | 16:52
Holding(s) in CompanyThu 25/07/19 | 16:00
Court of Appeals Rules on Indivior PatentsMon 15/07/19 | 14:40
Indivior Provides Statement on RB SettlementThu 11/07/19 | 13:18
Indivior PLC Raises FY 2019 GuidanceThu 11/07/19 | 07:00
Additional ListingMon 08/07/19 | 12:00
Holding(s) in CompanyFri 05/07/19 | 08:23
Notice of ResultsWed 03/07/19 | 07:00
Total Voting RightsMon 01/07/19 | 07:00
Holding(s) in CompanyTue 25/06/19 | 07:00
Indivior Presents RECOVER Study Data at CPDD 2019Tue 18/06/19 | 12:31
Holding(s) in CompanyFri 14/06/19 | 08:47
Holding(s) in CompanyWed 29/05/19 | 07:00
Holding(s) in CompanyFri 24/05/19 | 09:04
Holding(s) in CompanyFri 17/05/19 | 09:55
Indivior to Participate in ConferenceThu 16/05/19 | 07:00
Director/PDMR ShareholdingWed 15/05/19 | 07:00
Director/PDMR ShareholdingMon 13/05/19 | 15:43
Holding(s) in CompanyMon 13/05/19 | 07:00
Holding(s) in CompanyMon 13/05/19 | 07:00
Licensing of PERSERIS in CanadaThu 09/05/19 | 11:30
Block listing Interim ReviewThu 09/05/19 | 10:29
Result of AGMWed 08/05/19 | 13:54
Holding(s) in CompanyFri 03/05/19 | 07:00
1st Quarter ResultsThu 02/05/19 | 12:00
Holding(s) in CompanyThu 02/05/19 | 07:00
Holding(s) in CompanyWed 01/05/19 | 09:56
Holding(s) in CompanyMon 29/04/19 | 16:16
Holding(s) in CompanyMon 29/04/19 | 13:35
Holding(s) in CompanyMon 29/04/19 | 13:25
Holding(s) in CompanyMon 29/04/19 | 13:16
Change of Registered OfficeThu 18/04/19 | 09:24
Holding(s) in CompanyWed 17/04/19 | 15:26
Statement of Indivior on Grand Jury IndictmentWed 10/04/19 | 07:00
Holding(s) in CompanyTue 09/04/19 | 07:00
Indivior Presents RECOVER Study Data at ASAM 2019Mon 08/04/19 | 07:00
Indivior Announces New Data at ASAM ConferenceFri 05/04/19 | 13:30
Notice of ResultsThu 04/04/19 | 07:00
Holding(s) in CompanyWed 03/04/19 | 10:38
Holding(s) in CompanyMon 18/03/19 | 16:27
Holding(s) in CompanyFri 15/03/19 | 17:00
Annual Financial ReportThu 14/03/19 | 14:00
Directorate ChangeFri 08/03/19 | 14:30
Patient-centered Outcomes PublishedThu 07/03/19 | 14:00
Director/PDMR ShareholdingWed 06/03/19 | 10:37
Holding(s) in CompanyMon 04/03/19 | 16:54
Total Voting RightsFri 01/03/19 | 07:00
Holding(s) in CompanyThu 28/02/19 | 15:31
Indivior Launches PERSERIS (risperidone)Wed 27/02/19 | 13:00
Director DeclarationTue 26/02/19 | 15:10
Holding(s) in CompanyWed 20/02/19 | 09:06
Indivior Launches SUBOXONE Film Authorized GenericWed 20/02/19 | 07:00
The Lancet Publishes Phase 3 Results of SUBLOCADE(TM)Tue 19/02/19 | 07:00
Final ResultsThu 14/02/19 | 07:00
Federal Court Denies Motion to StayTue 12/02/19 | 07:00
Indivior Responds to CAFC Rehearing DecisionTue 05/02/19 | 07:00
Indivior Enters into Agreement with AlvogenMon 04/02/19 | 07:05
Indivior to Divest Interest in ChinaMon 04/02/19 | 07:00
Total Voting RightsFri 01/02/19 | 15:00
Indivior Granted Temporary Restraining OrderFri 25/01/19 | 07:00
Holding(s) in CompanyThu 24/01/19 | 09:28
Holding(s) in CompanyTue 22/01/19 | 15:51
Notice of ResultsMon 21/01/19 | 07:00
Holding(s) in CompanyWed 09/01/19 | 15:07
Holding(s) in CompanyThu 03/01/19 | 08:44
Indivior publishes real-world RECOVER study designThu 20/12/18 | 07:00
Indivior Trading UpdateTue 18/12/18 | 12:00
Holding(s) in CompanyThu 13/12/18 | 14:41
Federal Court Declines Immediate Issue of MandateWed 12/12/18 | 07:00
Indivior Prepays DebtFri 30/11/18 | 14:45
Holding(s) in CompanyThu 29/11/18 | 07:00
Holding(s) in CompanyWed 28/11/18 | 14:39
Indivior Announces Update CallTue 27/11/18 | 07:00
Health Canada Approves SUBLOCADE(TM)Fri 23/11/18 | 07:00
Holding(s) in CompanyWed 21/11/18 | 16:20
Holding(s) in CompanyWed 21/11/18 | 11:57
Indivior Responds to Federal Court DecisionWed 21/11/18 | 07:00
Second Price Monitoring ExtnTue 20/11/18 | 16:40
Price Monitoring ExtensionTue 20/11/18 | 16:35
INDIVIOR MAKES STATEMENT ON COURT DECISIONTue 20/11/18 | 15:28
Directorate ChangeMon 19/11/18 | 16:00
PERSERIS(TM) AvailabilityMon 19/11/18 | 13:02
Director DeclarationFri 16/11/18 | 15:52
Holding(s) in CompanyTue 13/11/18 | 16:22
Block listing Interim ReviewFri 09/11/18 | 15:00
Holding(s) in CompanyTue 06/11/18 | 14:37
Indivior Announces Upcoming Investor EventsTue 06/11/18 | 07:00
3rd Quarter ResultsThu 01/11/18 | 11:01
Total Voting RightsThu 01/11/18 | 07:00
Holding(s) in CompanyWed 31/10/18 | 13:12
Holding(s) in CompanyTue 30/10/18 | 08:53
Indivior Applauds New U.S. Opioid LegislationThu 25/10/18 | 07:00
Holding(s) in CompanyTue 23/10/18 | 15:55
Notice of ResultsWed 17/10/18 | 07:00
Holding(s) in CompanyFri 05/10/18 | 16:04
Holding(s) in CompanyFri 28/09/18 | 16:29
Second Price Monitoring ExtnWed 26/09/18 | 16:41
Price Monitoring ExtensionWed 26/09/18 | 16:35
Indivior Provides Business UpdateWed 26/09/18 | 16:19
Holding(s) in CompanyThu 20/09/18 | 15:50
Director DeclarationWed 19/09/18 | 15:35
Indivior unable to attend Investor ConferenceWed 12/09/18 | 07:00
Indivior Prepays $150 Million of Outstanding DebtMon 10/09/18 | 07:00
Morgan Stanley Annual Global Healthcare ConferenceTue 04/09/18 | 07:00
Holding(s) in CompanyTue 21/08/18 | 16:37
Holding(s) in CompanyFri 10/08/18 | 15:38
Holding(s) in CompanyMon 06/08/18 | 16:19
Total Voting RightsWed 01/08/18 | 07:00
Indivior Preliminary Injunction UpheldTue 31/07/18 | 07:00
DRL's Appeal of Indivior's PI Granted-in-PartMon 30/07/18 | 07:01
US FDA Approves Indivor's PERSERIS(TM)Mon 30/07/18 | 07:00
Holding(s) in CompanyFri 27/07/18 | 08:40
Holding(s) in CompanyThu 26/07/18 | 09:01
Half-year ReportWed 25/07/18 | 07:00
Holding(s) in CompanyTue 24/07/18 | 07:00
US Court Grants Indivior Preliminary InjunctionMon 16/07/18 | 07:00
Holding(s) in CompanyFri 13/07/18 | 16:39
Holding(s) in CompanyThu 12/07/18 | 17:16
Indivior Sees FY18 Guidance Below ExpectationsWed 11/07/18 | 07:00
Notice of ResultsTue 10/07/18 | 07:00
Holding(s) in CompanyTue 03/07/18 | 07:01
Holding(s) in CompanyTue 03/07/18 | 07:00
Indivior's Temporary Restraining Order is ExtendedFri 29/06/18 | 07:00
Holding(s) in CompanyThu 21/06/18 | 14:56
Holding(s) in CompanyWed 20/06/18 | 07:00
Indivior Is Granted Temporary Restraining OrderMon 18/06/18 | 07:00
Holding(s) in CompanyFri 15/06/18 | 15:56
Indivior Responds to Generic SUBOXONE ® ApprovalsFri 15/06/18 | 13:59
Holding(s) in CompanyThu 07/06/18 | 09:30
Total Voting RightsFri 01/06/18 | 07:00
California Department of Insurance subpoenaThu 31/05/18 | 07:00
SUBLOCADE(TM) Submitted in Australia for ApprovalFri 25/05/18 | 14:25
Indivior Participating in Jefferies NYC ConferenceThu 24/05/18 | 07:00
Result of AGMWed 16/05/18 | 17:50
Indivior settlement with Par PharmaceuticalMon 14/05/18 | 07:00
Block listing Interim ReviewThu 10/05/18 | 11:40
Director/PDMR ShareholdingFri 04/05/18 | 14:13
1st Quarter ResultsWed 02/05/18 | 07:00
Indivior's SUBLOCADE NDS Accepted by Health CanadaFri 20/04/18 | 07:00
Holding(s) in CompanyThu 12/04/18 | 15:56
Director DeclarationWed 11/04/18 | 16:02
Notice of ResultsWed 11/04/18 | 07:00
Holding(s) in CompanyFri 06/04/18 | 09:31
Indivior Asserts New SUBOXONE(R) Film PatentThu 05/04/18 | 07:00
Director/PDMR ShareholdingWed 04/04/18 | 09:28
Holding(s) in CompanyTue 03/04/18 | 09:33
Total Voting RightsTue 03/04/18 | 07:00
Indivior and C4X Enter Licensing AgreementThu 29/03/18 | 07:00
Holding(s) in CompanyTue 27/03/18 | 16:13
Indivior Responds to Court Ruling ANDA litigationFri 23/03/18 | 07:00
Annual Financial ReportThu 22/03/18 | 13:39
Director/PDMR ShareholdingTue 13/03/18 | 15:14
Director/PDMR ShareholdingMon 12/03/18 | 16:30
Holding(s) in CompanyFri 02/03/18 | 14:51
Holding(s) in CompanyFri 02/03/18 | 10:24
Indivior Announces SUBLOCADE (TM) Available in USThu 01/03/18 | 13:00
Total Voting RightsThu 01/03/18 | 07:00
Director/PDMR ShareholdingWed 28/02/18 | 17:45
Holding(s) in CompanyWed 28/02/18 | 16:53
Holding(s) in CompanyMon 19/02/18 | 07:00
Final ResultsThu 15/02/18 | 07:00
Holding(s) in CompanyWed 14/02/18 | 09:50
Holding(s) in CompanyMon 12/02/18 | 15:49
Holding(s) in CompanyThu 08/02/18 | 15:27
Indivior asserts new patent against ANDA-filersThu 08/02/18 | 07:00
Holding(s) in CompanyTue 06/02/18 | 14:14
Total Voting RightsThu 01/02/18 | 07:05
Indivior Provides Update on Tax PositionThu 01/02/18 | 07:00
Notice of ResultsFri 19/01/18 | 07:00
Holding(s) in CompanyMon 08/01/18 | 09:24
J.P. Morgan Healthcare ConferenceThu 04/01/18 | 13:00
Indivior and Addex Enter Strategic CollaborationWed 03/01/18 | 07:00
Indivior amends and extends $534m debt facilitiesTue 19/12/17 | 07:00
Indivior's RBP-7000 NDA Accepted by FDATue 12/12/17 | 07:00
Additional ListingFri 08/12/17 | 07:00
FDA Approves SUBLOCADE (TM)Fri 01/12/17 | 07:00
Holding(s) in CompanyThu 23/11/17 | 13:46
Block listing Interim ReviewFri 10/11/17 | 16:02
Jefferies London Healthcare ConferenceMon 06/11/17 | 07:00
Board Committee ChangesThu 02/11/17 | 13:28
Holding(s) in CompanyThu 02/11/17 | 11:40
3rd Quarter ResultsThu 02/11/17 | 11:00
FDA Advisory Committees Vote to Approve RBP-6000Wed 01/11/17 | 07:00
Notice of ResultsTue 10/10/17 | 07:00
Holding(s) in CompanyMon 09/10/17 | 13:17
FDA Posts Advisory Committee Notice for RBP-6000Tue 03/10/17 | 16:00
RBP-7000 - Submission of NDA to U.S. FDAMon 02/10/17 | 07:00
Indivior settlement with Mylan PharmaceuticalsMon 25/09/17 | 07:00
Holding(s) in CompanyThu 21/09/17 | 15:36
Holding(s) in CompanyThu 21/09/17 | 09:37
Indivior asserts new patent against ANDA-filersFri 15/09/17 | 07:00
Holding(s) in CompanyMon 11/09/17 | 09:50
Total Voting RightsFri 01/09/17 | 15:04
Indivior to appeal court rulings ANDA litigationFri 01/09/17 | 07:00
Holding(s) in CompanyThu 31/08/17 | 17:21
Morgan Stanley Annual Global Healthcare ConferenceWed 30/08/17 | 17:00
Holding(s) in CompanyMon 14/08/17 | 07:00
Director/PDMR Shareholding (Replacement)Thu 10/08/17 | 16:36
Holding(s) in CompanyTue 08/08/17 | 11:24
Holding(s) in CompanyTue 08/08/17 | 11:16
Holding(s) in CompanyTue 08/08/17 | 11:14
Holding(s) in CompanyTue 08/08/17 | 11:10
Holding(s) in CompanyWed 02/08/17 | 11:08
Total Voting RightsTue 01/08/17 | 07:00
Holding(s) in CompanyMon 31/07/17 | 15:58
Indivior's NALSCUE® Receives ANSM MA for FranceMon 31/07/17 | 07:30
RBP-6000 NDA Receives FDA Priority ReviewMon 31/07/17 | 07:00
Half Year Financial ResultsThu 27/07/17 | 07:00
Notice of ResultsThu 13/07/17 | 14:00
RBP-6000 Investor Event ReminderThu 29/06/17 | 11:00
RBP-6000 Investor EventFri 16/06/17 | 14:00